Nina T. Tikhonova

Nina T. Tikhonova

Auto-generated profile, based on publicly available information

Nina T. Tikhonova

G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
JHJudith M. Hübschen
Judith M. Hübschen
ZMZefira Mihneva
Zefira Mihneva
AMAndreas F. Mentis
Andreas F. Mentis
FSFrançoIs Schneider
FrançoIs Schneider
YAYair Aboudy
Yair Aboudy
CMClaude P. Muller
Claude P. Muller
Phylogenetic analysis of 166 human parvovirus B19 sequences from 11 different countries attributed 91.57% to genotype 1, 5.42% to genotype 3b, and 3.01% to genotype 3a. Very similar viruses of genotype 1 circulated widely in Europe and Israel. Genotype 3b seems to show an increasing spread outside of Africa.

1 July 2011 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
EAEmily S. Abernathy
Emily S. Abernathy
JHJudith M. Hübschen
Judith M. Hübschen
CMClaude P. Muller
Claude P. Muller
LJLi Jin
Li Jin
DBDavid Brown
David Brown
JIJoseph P. Icenogle
Joseph P. Icenogle
The suspected measles case definition captures rubella cases. Therefore, measles surveillance will be improved in the course of the control and eventual elimination of rubella transmission. One aspect of rubella control, virologic surveillance, is reviewed here. A systematic nomenclature for rubella viruses (RVs) based on 13 genotypes has been established and is updated when warranted by increases in information about RVs. From 2005 through 2010, the genotypes of RVs most frequently reported were 1E, 1G, and 2B, and genotypes 1a, 1B, 1C, 1h, 1j, and 2C were less frequently reported. Virologic surveillance can support rubella control and elimination. Synopses of rubella virologic surveillance in various countries, regions, and globally are given, including characterization of viruses from imported cases in a country that has eliminated rubella and studies of endemic viruses circulating in countries without rubella control objectives. Current challenges are discussed.

1 July 2011 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
GOG. Onishchenko
G. Onishchenko
EEE. Ezhlova
E. Ezhlova
AGA. Gerasimova
A. Gerasimova
OTO. Tsvirkun
O. Tsvirkun
SSS. Shulga
S. Shulga
NTN. Tikhonova
N. Tikhonova
Successful implementation of the Russian Federation's national measles elimination program has been ensured by high vaccine coverage (>95%) of the target population (with 2 doses of measles-containing vaccine), case-based laboratory investigation of measles, and active surveillance of measles cases among patients with rashes and/or fever. As a result, the incidence of measles has decreased to <1 case per 1,000,000 population (2007–2009); no circulation of D6 genotype, which was endemic in the Russian Federation, has been observed since the second half of 2007; and the proportion of imported measles cases of different genotypes increased to 19.8% in 2007 from 1% in 2003. To confirm successful elimination of indigenous measles, a documentation system was initiated in the Russian Federation.

1 July 2011 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AMAnnette Mankertz
Annette Mankertz
MMMick N. Mulders
Mick N. Mulders
SSSergey Shulga
Sergey Shulga
JKJacques R. Kremer
Jacques R. Kremer
KBKevin E. Brown
Kevin E. Brown
EGEugene Gavrilin
Eugene Gavrilin
Background. In 2002, the World Health Organization (WHO) adopted a goal to eliminate measles in the European Region by 2010. Measles elimination is defined as the interruption of indigenous measles virus (MV) transmission. The molecular epidemiology of MV transmission in the WHO European Region was studied through the investigation of reported cases and outbreaks to monitor the region's progress toward its measles elimination goal.

1 February 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
JKJulia R. Kessler
Julia R. Kessler
JKJacques R. Kremer
Jacques R. Kremer
SSSergey V. Shulga
Sergey V. Shulga
NTNina T. Tikhonova
Nina T. Tikhonova
SSSabine Santibanez
Sabine Santibanez
CMClaude P. Muller
Claude P. Muller
With improved measles virus (MV) control, the genetic variability of the MV-nucleoprotein hypervariable region (NP-HVR) decreases. Thus, it becomes increasingly difficult to determine the origin of a virus using only this part of the genome. During outbreaks in Europe and Africa, we found MV strains with identical NP-HVR sequences. However, these strains showed considerable diversity within a larger sequencing window based on concatenated MV phosphoprotein and hemagglutinin genes (P/H pseudogenes). In Belarus, Germany, Russia, and the Democratic Republic of Congo, the P/H pseudogenes provided insights into chains of transmission, whereas identical NP-HVR provided none. In Russia, for instance, the P/H pseudogene identified temporal clusters rather than geographical clusters, demonstrating the circulation and importation of independent variants rather than large local outbreaks lasting for several years, as suggested by NP-HVR. Thus, by extending the sequencing window for molecular epidemiology, a more refined picture of MV circulation was obtained with more clearly defined links between outbreaks and transmission chains. Our results also suggested that in contrast to the P gene, the H gene acquired fixed substitutions that continued to be found in subsequent outbreaks, possibly with consequences for its antigenicity. Thus, a longer sequencing window has true benefits both for the epidemiological surveillance of measles and for the better monitoring of viral evolution.

11 September 2020 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
OTO. V. Tsvirkun
O. V. Tsvirkun
NTN. T. Tikhonova
N. T. Tikhonova
EEE. B. Ezhlova
E. B. Ezhlova
АМА. А. Мельникова
А. А. Мельникова
AGA. G. Gerasimova
A. G. Gerasimova
Характеристика популяционного иммунитета к кори в Российской Федерации